BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11459994)

  • 1. Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy.
    Caponigro F; Avallone A; Budillon A; Comella P; Comella G
    Anticancer Drugs; 2001 Jul; 12(6):489-97. PubMed ID: 11459994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
    Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).
    Caponigro F; Comella P; Rivellini F; Avallone A; Budillon A; Di Gennaro E; Mozzillo N; Ionna F; De Rosa V; Manzione L; Comella G
    Ann Oncol; 2000 May; 11(5):575-80. PubMed ID: 10907951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of mitoxantrone, raltitrexed, levofolinic acid and 5-fluorouracil in advanced solid tumours.
    Caponigro F; Avallone A; Rivellini F; Comella P; Ionna F; De Rosa V; Comella G
    Cancer Chemother Pharmacol; 2001; 47(2):113-6. PubMed ID: 11269736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
    Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
    Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C; Zucali P; Garassino I
    Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raltitrexed: current clinical status and future directions.
    Van Cutsem E; Cunningham D; Maroun J; Cervantes A; Glimelius B
    Ann Oncol; 2002 Apr; 13(4):513-22. PubMed ID: 12056700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group.
    Comella P; De Vita F; De Lucia L; Casaretti R; Avallone A; Orditura M; Rivellini F; Palmeri S; Catalano G; Comella G
    Ann Oncol; 2000 Apr; 11(4):461-8. PubMed ID: 10847467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raltitrexed-based chemotherapy for advanced colorectal cancer.
    Liu Y; Wu W; Hong W; Sun X; Wu J; Huang Q
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):219-25. PubMed ID: 24388340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study.
    Avallone A; Delrio P; Guida C; Tatangelo F; Petrillo A; Marone P; Cascini LG; Morrica B; Lastoria S; Parisi V; Budillon A; Comella P
    Br J Cancer; 2006 Jun; 94(12):1809-15. PubMed ID: 16736001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectives.
    Van Cutsem E
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S1-2. PubMed ID: 10645206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
    Armand JP; Seymour L; Evans TR
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S14-8. PubMed ID: 10645209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raltitrexed and oxaliplatin in colorectal cancer: in vitro and in vivo study of a synergistic cytostatic combination].
    Schüll B; Scheithauer W
    Acta Med Austriaca; 2002; 29(4):124-31. PubMed ID: 12424937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas.
    Gebbia V; Verderame F; Ferraù F; Bordonaro R; Callari A; Caruso M; Tirrito ML; Valenza R; Cicero G; Borsellino N; Tralongo P
    Ann Oncol; 2006 Jun; 17 Suppl 7():vii60-5. PubMed ID: 16760296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.
    Avallone A; Di Gennaro E; Bruzzese F; Laus G; Delrio P; Caraglia M; Pepe S; Comella P; Budillon A
    Anticancer Drugs; 2007 Aug; 18(7):781-91. PubMed ID: 17581300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma.
    Laudani A; Gebbia V; Leonardi V; Savio G; Borsellino N; Cusimano MP; Calabria C; Stefano R; Agostara B
    Anticancer Res; 2004; 24(2C):1139-42. PubMed ID: 15154638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raltitrexed and mitomycin-C as third-line chemotherapy for colorectal cancer after combination regimens including 5-fluorouracil, irinotecan and oxaliplatin: a phase II study.
    Rosati G; Rossi A; Germano D; Reggiardo G; Manzione L
    Anticancer Res; 2003; 23(3C):2981-5. PubMed ID: 12926149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).
    Cascinu S; Graziano F; Ferraù F; Catalano V; Massacesi C; Santini D; Silva RR; Barni S; Zaniboni A; Battelli N; Siena S; Giordani P; Mari D; Baldelli AM; Antognoli S; Maisano R; Priolo D; Pessi MA; Tonini G; Rota S; Labianca R
    Ann Oncol; 2002 May; 13(5):716-20. PubMed ID: 12075739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trials.
    Schwartz GK; Harstrick A; González Barón M
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S9-13. PubMed ID: 10645208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.